Jianguo Cheng, MD, PhD, FIPP is Past President of American Academy of Pain Medicine (AAPM) and immediate past Chair of the US Section of World Institute of Pain. He has recently been appointed to the US Department of Health and Human Services (HHS) Pain Management Best Practices Inter-agency Task Force (PMTF) to propose updates to best practices and issue recommendations that address gaps or inconsistencies for managing chronic and acute pain. Dr. Cheng is also a member of the Centers for Medicare & Medicaid Services (CMS) Expert Work Group (EWG) to develop, specify, and maintain clinical quality measures.
As a physician investigator, Dr. Cheng has directed basic, translational, and clinical investigations of stem cells, opioid tolerance, and chronic pain. His research is supported by research grants from the National Institutes of Health (NIH), the Department of Defense, and other funding agencies.
Dr. Cheng has published more than 250 articles including investigations on opioid tolerance and neuropathic pain. As an educator, Dr. Cheng has published two textbooks (Springer-Nature) (Oxford University Press) and has given more than 150 lectures/presentations world-wide. He has trained more than 150 clinical pain fellows and postdoctoral research fellows. In addition, Dr. Cheng has played active leadership roles in the Association of University Anesthesiologists (AUA), American Board of Anesthesiology (ABA), American Society of Anesthesiologists (ASA), and American Academy of Regenerative Medicine. He has served as Senior Editor, Associate Editor, and Section Editor for the scientific journals of “Pain Medicine”, “Pain Practice”, and “Pain Physician”.